Skip to main content

UPDATE 1-Esperion's cholesterol drug gets U.S. approval; to be priced at $10 per pill

The U.S Food and Drug Administration approved Esperion Therapeutics Inc's cholesterol-lowering drug as an add-on treatment to commonly used statins, the agency said on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.